Boston, Feb. 05, 2016 -- Informa’s Pharma Intelligence– the world’s leading provider of clinical and research intelligence and analysis, and home of leading brands such as Sitetrove, In Vivo, Pink Sheet, Scrip and Biomedtracker – is announcing the launch of the first annual Clinical and Research Excellence Awards. The CARE Awards, as they will be known throughout the pharma and healthcare industry, will be held in Boston’s State Room on 27th April, 2016, and will recognize the outstanding achievements of the global clinical research enterprise.
“The CARE Awards will gather together distinguished leaders in the biopharmaceutical, CRO and diagnostic industries from all corners of the globe,” says Alex Shimmings, Editor of Scrip.
“These awards are designed to be the pre-eminent awards for clinical and research excellence and will celebrate the brilliant minds, strategic thinkers and risk takers who bring the hope and promise of good health to humankind across the globe,” adds Shimmings. “We are celebrating those individuals and companies who have dedicated themselves to improving the health and well-being of others.”
The CARE Awards features 12 categories that reward innovation, technological development, collaboration and excellence in areas such as successful trials, clinical trial design, R&D excellence, partnerships and lifetime achievement.
“The CARE Awards provides our industry with the opportunity to showcase those who work in clinical research and development and to honor both individuals and companies that shine through innovation, excellence and leadership,” explains Doro Shin, Principal Analyst at Citeline, the world’s leading authority on pharmaceutical clinical trials.
Nominations for the CARE Awards is free and all submissions should be made via the online entry form available here www.clinicalresearchexcellence.com. A panel of distinguished industry experts will rigorously assess entries and decide upon winners in each of the categories for the 2016 CARE Awards.
The first annual CARE Awards categories include:
- Most Successful Early Phase Trial (Preclinical & Phase I)
- Most Innovative Clinical Trial Design
- Clinical Trial Result of the Year
- Best Advance in Biomarkers
- Best Technological Development in Clinical Trials
- R&D Team of the Year
- Clinical Research Team of the Year
- Clinical Partnership of the Year
- Best Use of Companion Diagnostic
- Best Newcomer (Company)
- Marquee Award ‘R&D Excellence’
- Lifetime Achievement
“Innovative thinking, determination to succeed and dedication to improving healthcare are hallmarks of our great industry,” continues Shin. “The 2016 shortlisted candidates will all share the attributes that make clinical R&D both a global economic force and a force for the good of humankind. Together with our esteemed panel of judges, we look forward to a strong ‘class of 2016’ and we welcome entries from around the world.”
-ENDS-
For press enquiries contact:
Kirstin Stocker
Tel: +44 (0)207 017 7290
Mobile: +44 (0)79 205 00400
Email: [email protected]
For Sponsorship enquiries contact:
Matt Dias Tel: +44 (0)207 017 4188
Mobile: +44 (0)770 235 3220
Email: [email protected]
For all other enquiries contact:
Jo Kirkpatrick (UK)
Tel: +44 (0) 207 017 7180
Email: [email protected]
About Pharma intelligence
Pharma intelligence is home of the world’s leading pharma and healthcare R&D and business intelligence brands – Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack, Biomedtracker, Scrip, Pink Sheet, In Vivo. Pharma intelligence’s brands are trusted to provide over 3000 of the world’s leading pharmaceutical, contract research organisations (CRO’s), medical technology, biotechnology and healthcare service providers, including the top 10 global pharma and top 10 CRO’s, with an advantage when making critical R&D and commercial decisions.


Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Italy Fines Apple €98.6 Million Over App Store Dominance 



